News Focus
News Focus
icon url

georgejjl

10/09/22 4:16 PM

#376909 RE: boi568 #376908

Keep in mind that accrued deficits from Blarcamesine development and trials can and will be used to reduced tax liabilities in future years. This can and will save millions of Anavex Life Sciences for the first years of profitability.

GOD bless,